Compare BIO & RRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | BIO | RRX |
|---|---|---|
| Founded | 1952 | 1955 |
| Country | United States | United States |
| Employees | 7450 | 29200 |
| Industry | Biotechnology: Laboratory Analytical Instruments | |
| Sector | Industrials | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.9B | 13.7B |
| IPO Year | N/A | 1994 |
| Metric | BIO | RRX |
|---|---|---|
| Price | $281.09 | $187.33 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 4 | 10 |
| Target Price | ★ $339.75 | $210.70 |
| AVG Volume (30 Days) | 380.5K | ★ 1.1M |
| Earning Date | 04-30-2026 | 05-06-2026 |
| Dividend Yield | N/A | ★ 0.69% |
| EPS Growth | N/A | ★ 42.86 |
| EPS | N/A | ★ 0.96 |
| Revenue | N/A | ★ $3,257,100,000.00 |
| Revenue This Year | $2.74 | $4.20 |
| Revenue Next Year | $3.20 | $12.13 |
| P/E Ratio | ★ $9.72 | $194.99 |
| Revenue Growth | N/A | ★ 5.21 |
| 52 Week Low | $211.43 | $127.96 |
| 52 Week High | $343.12 | $236.35 |
| Indicator | BIO | RRX |
|---|---|---|
| Relative Strength Index (RSI) | 58.14 | 38.55 |
| Support Level | $253.20 | $177.02 |
| Resistance Level | $288.48 | $222.63 |
| Average True Range (ATR) | 9.74 | 9.22 |
| MACD | 2.05 | -3.65 |
| Stochastic Oscillator | 91.48 | 11.68 |
Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and sells products and solutions for the clinical diagnostics and life sciences markets. In clinical diagnostics (60% of sales), Bio-Rad sells test systems and specialized quality controls for clinical laboratories. In life sciences (40% of sales), it develops and manufactures instruments and reagents used in research, biopharmaceutical production, and food testing and has a leadership position in dPCR technology. The company is geographically diverse, with major markets in the Americas (about 40% of sales), Europe (about 30%), Asia (about 30%), and other. Bio-Rad owns approximately 33% of Sartorius, a lab and bioprocessing supplier that specializes in single-use technology used in biologics manufacturing.
Regal Rexnord Corp is in the engineering and manufacturing of industrial powertrain solutions, power transmission components, electric motors, electronic controls, air-moving products, and specialty electrical components and systems, serving customers around the world. The three operating segments include Automation & Motion Control (AMC) segment; Industrial Powertrain Solutions (IPS) segment, which derives maximum revenue; and Power Efficiency Solutions (PES) segment. Geographically, the company operates in North America, Europe, Asia, and Rest of the world, of which it derives maximum revenue from North America.